Dapagliflozin targets RORγt to improve myocardial ischemia-reperfusion injury-induced heart failure by regulating the CD4+ T cell/Th17 cell axis within cardiac tissue
Fields of Study & Subjects
Cardiac Fibrosis and Remodeling
Atherosclerosis and Cardiovascular Diseases
Cardiovascular Function and Risk Factors
Publication details
- Journal / source
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Volume
- 1872
- Issue
- 4
- Pages
- 168185–168185
- Publication date
- 4 February 2026
- Language
- EN